[Experience with using amedin in children with movement disorders of extrapyramidal and labyrinth origin].
Using previously obtained data concerning the effectivity of amedin in motor and speech disorders due to muscular dystonia the drug was used for the treatment of 50 children from 3.5 months to 18 years, with motor disorders of an extrapyramidal and labyrinth nature. A high therapeutical effectivity of amedin in an increased pathological activity of tonic cervical and labyrinth reflexes in infants and in torsion spasm of school age children is demonstrated.
D000293:Adolescent; D001480:Basal Ganglia Diseases / Q000188:drug therapy; D002547:Cerebral Palsy / Q000188:drug therapy; D002648:Child; D002675:Child, Preschool; D004422:Dystonia Musculorum Deformans / Q000188:drug therapy; D006016:Glycolates / Q000627:therapeutic use*; D006801:Humans; D007759:Labyrinth Diseases / Q000150:complications; D008333:Mandelic Acids; D009069:Movement Disorders / Q000188:drug therapy* / Q000209:etiology; D010276:Parasympatholytics / Q000627:therapeutic use*; D012021:Reflex, Abnormal / Q000188:drug therapy; D013577:Syndrome
D006016:Glycolates; D008333:Mandelic Acids; D010276:Parasympatholytics; C016215:amedin
Opyt primeneniia amedina pri dvigatel'nykh narusheniiakh ékstrapiramidnogo i labirintnogo proiskhozhdeniia u deteĭ.